Achillion Pharmaceuticals Inc Issues FY 2013 EPS Guidance In Line With Analysts' Estimates


Wednesday, 20 Feb 2013 04:08pm EST 

Achillion Pharmaceuticals Inc announced that for fiscal 2013 the net loss per share (EPS) is anticipated to approximate $0.75 per share for fiscal 2013. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of ($0.75) for fiscal 2013. 

Company Quote

14.21
-0.335 -2.30%
19 Dec 2014